Asgpr-binding compounds for the degradation of extracellular proteins
US-2024424108-A1 · Dec 26, 2024 · US
US10808253B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10808253-B2 |
| Application number | US-201616066468-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 28, 2016 |
| Priority date | Dec 28, 2015 |
| Publication date | Oct 20, 2020 |
| Grant date | Oct 20, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
In this formula, X, Y, and Z each represent an amino acid residue independently selected from the group consisting of R, G, S, K, T, L, N, Q, and H, with the proviso that at least one Y represents K, L, N, Q, H, or R. m represents an integer of 0 to 5; n represents 1, 2, or 3; q represents an integer of 1 to 10; and r represents an integer of 0 to 10.
Opening claim text (preview).
The invention claimed is: 1. A peptide comprising the amino acid sequence of SEQ ID NO: 25, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 54, 64, 66, 102, 104, 106, 112, 114, 116, 118, 122, 124, 132, 136, 140, 142, 147, 149, 151, 153, or 157. 2. A tagged protein comprising: the peptide according to claim 1 and a protein. 3. The tagged protein according to claim 2 , wherein the protein is selected from the group consisting of human growth hormone, interferon β, xylanase, esterase, and green fluorescent protein (GFP). 4. The tagged protein according to claim 2 , wherein the peptide is linked to the protein through a protease recognition sequence. 5. The tagged protein according to claim 2 , further comprising: a secretion signal. 6. A DNA encoding the tagged protein according to claim 2 . 7. A recombinant vector comprising: the DNA according to claim 6 . 8. A transformant prepared by transformation with the DNA according to claim 6 . 9. The transformant according to claim 8 , wherein the transformant is yeast, E. coli, Brevibacillus , an insect cell, or a mammalian cell, and wherein the mammalian cell comprises a human cultured cell, but does not comprise a human individual. 10. A method for producing a tagged protein, comprising: culturing the transformant according to claim 8 to allow accumulation of the tagged protein, and collecting the tagged protein. 11. A transformant prepared by transformation with the recombinant vector according to claim 7 . 12. A peptide consisting of the amino acid sequence of SEQ ID NO: 52, 58, 60, 92, 94, 96, 100, 108, 110, 120, 128, 130, 134, 145, or 155. 13. The peptide of claim 12 , wherein peptide consists of the amino acid sequence of SEQ ID NO: 52, 58, 60, 92, 94, 96, 100, 108, 110, 120, 130, 134, 145, or 155.
PCR · CPC title
Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence) · CPC title
from mammals · CPC title
from insects · CPC title
from yeasts · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.